Latest IDEXX News & Updates

See the latest news and media coverage for IDEXX. We track all announcements, press releases, and industry mentions in real time, all in one place.

IDEXX

Veterinary diagnostics and animal health technology company

idexx.com

Headquarters: Westbrook, United States
Founded year: 1983
Company type: Public company
Number of employees: 10,000+
Industry: Medical Equipment, Supplies & Distribution

Last updated September 16

Latest news about IDEXX

In short: IDEXX posted strong growth, raised guidance, named a new CEO, and expanded AI, cancer, and cardiac diagnostics.

Company announcements

August 4 IDEXX

IDEXX Laboratories announces second quarter 2026 financial results

Revenue grew 10% as reported and 9% organic to $1.22 billion; EPS rose 18% to $4.27; the company raised its full-year guidance.

July 28 IDEXX

IDEXX releases 2025 Corporate Responsibility Report

The report highlights progress on innovation, people, and environmental goals, including GHG emission reductions and access to care.

May 26 IDEXX

IDEXX expands Fecal Dx platform with taeniid tapeworm detection

The expansion adds detection of Taenia and Echinococcus species, broadening intestinal parasite screening in routine care.

May 5 IDEXX

IDEXX announces Q1 2026 results

Reports 14% revenue growth to $1,141 million, EPS of $3.47 up 17%, and raises full-year guidance.

Media coverage

September 16 RTTNews

IDEXX Buys CoVetAI To Expand Veterinary Workflow Intelligence

Veterinary diagnostics company IDEXX Laboratories, Inc. announced on Wednesday that it has acquired CoVetAI Inc., a provider of AI-native ambient listening and clinical workflow s...

September 8 Investing.com

IDEX stock hits 52-week low of $517.00

In other recent developments, IDEXX Laboratories reported second-quarter earnings that beat Wall Street expectations, driven by increased demand for diagnostics, improved...

August 20 Yahoo Finance

IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve

IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.

August 11 TMCnet

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst™ proBNP Test, the first and only...

Never miss news about IDEXX

Track IDEXX and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.